Could less be more? new study cuts chemo and radiation for HPV throat cancer

NCT ID NCT06902623

First seen Apr 24, 2026 · Last updated May 16, 2026 · Updated 4 times

Summary

This study is for people with early-stage HPV-positive throat cancer. Standard treatment uses full-dose radiation plus chemotherapy, which can cause long-term side effects. The study tests whether giving only lower-dose radiation (no chemo) can keep the cancer from coming back while reducing side effects. About 30 adults with stage I-II HPV-positive oropharyngeal cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medstar Georgetown University Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20007, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Medstar Southern Maryland Hospital Center

    RECRUITING

    Clinton, Maryland, 20735, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.